Keywords
stroke
ACE inhibitor
Facial orolingual angioedema
How to Cite
Abstract
Clinical snapshot on "Alteplase-induced Facial Orolingual Angioedema" presented in volume 5 issue 1 of ICTUS.
References
Alakbarzade, Vafa; O’Kane, Declan; Pereira, Anthony C (2019). Hypersensitivity reactions to recombinant tissue plasminogen activator. Practical Neurology, (), practneurol-2018-002189–.doi:10.1136/practneurol-2018-002189
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;50(12):e344-e418.
Hill, M. D. (2005). Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. Canadian Medical Association Journal, 172(10), 1307–1312. https://doi.org/10.1503/cmaj.1041561
Hurford, R., Rezvani, S., Kreimei, M., Herbert, A., Vail, A., Parry-Jones, A. R., Douglass, C., Molloy, J., Alachkar, H., Tyrrell, P. J., & Smith, C. J. (2014). Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke. Journal of Neurology, Neurosurgery & Psychiatry, 86(5), 520–523. https://doi.org/10.1136/jnnp-2014-308097
Frigas, E., & Park, M. A. (2009). Acute Urticaria and Angioedema. American Journal of Clinical Dermatology, 10(4), 239–250. https://doi.org/10.2165/00128071-200910040-00004
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Amado Jiménez-Ruiz (Autor); Ricardo Gabriel Ascencio-Tene; Juan Carlos Ayala-Alvarez (Autor); Iván Roque-Sánchez; Santiago Alba-Valencia, Jose Luis Ruiz-Sandoval (Autor)